IHE icon

iShares US Pharmaceuticals ETF
IHE

Overview Fund Activity

93 hedge funds and large institutions have $60.9M invested in iShares US Pharmaceuticals ETF in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 32 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
-2
Holders Change %
-2.11%
% of All Funds
2.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
22
Reduced
32
Closed
11
Calls
$1.14M
Puts
$800K
Net Calls
+$344K
Net Calls Change
+$693K

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$3.21M
2
RJA
2
Raymond James & Associates
Florida
$2.8M
3
SRSA
3
S.R. Schill & Associates
Washington
$1.3M
4
CG
4
Cutler Group
California
$376K
5
Janney Montgomery Scott
5
Janney Montgomery Scott
Pennsylvania
$453K

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$315K
2
Fisher Asset Management
2
Fisher Asset Management
Washington
$1.63M
3
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$3.53M
4
Citadel Advisors
4
Citadel Advisors
Florida
$3.37M
5
Bank of America
5
Bank of America
North Carolina
$3.19M
Name Holding Trade Value Shares
Change 		Shares
Change %
TI
101
tru Independence
Oregon
– -$8K -180 Closed
APWM
102
Atlas Private Wealth Management
New York
– -$6K -108 Closed
APA
103
American Portfolios Advisors
New York
– -$5.12K -96 Closed
DY
104
Dowling & Yahnke
California
– -$5K -90 Closed
1 2 3 4
5